Delivery Order SPE2DB22D2211-SPE2DB24FMSJ4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,667.38 delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,658.76 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has an ultimate completion date of October 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,015.85 firm fixed price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award, valued at $9,023.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is made under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide a range of...
- This federal contract award is a delivery order worth $47,077.25 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is a firm fixed-price delivery order for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen Drug Corp is the prime contractor and the contract does not have a...
- This federal contract award, valued at $26,311.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of January 28, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated with a set-aside requirement, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,168.09 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has a performance period through July 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,307.15 Firm Fixed Price Delivery Order contract is to provide the DLA with RINVOQ ER 15 MG TABLET. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $9,023.13, is for the supply of RINVOQ ER 15 MG TABLET UU 30S medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,884.59 firm fixed price delivery order is for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. This award does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMSJ4Delivery Order
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The award, valued at $3,216.90, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a specialty pharmaceutical product. The contract is a firm fixed price agreement with a period of performance through January 31, 2024. The award does not have any set-aside designations. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, providing medical supplies and pharmaceutical products to support U.S. Department of Defense military treatment programs and facilities. The company also holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to deliver a comprehensive range of medications and healthcare materials to the agency through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/30/24 |